Augmentin Dosing Recommendations
For most adult infections, Augmentin 875 mg/125 mg twice daily is the preferred oral regimen, providing optimal coverage for respiratory, skin/soft tissue, and urinary tract infections while minimizing gastrointestinal side effects compared to three-times-daily dosing. 1
Standard Adult Oral Dosing Regimens
Twice-Daily Dosing (Preferred for Most Infections)
- Augmentin 875 mg/125 mg twice daily is specifically recommended for respiratory infections including acute bacterial rhinosinusitis, community-acquired pneumonia, and acute exacerbations of chronic bronchitis 1
- This formulation is also indicated for skin and soft tissue infections, urinary tract infections, and animal or human bites 1
- The 875 mg formulation should be chosen for standard community-acquired infections and empiric therapy 1
Three-Times-Daily Dosing (Alternative Regimen)
- Augmentin 500 mg/125 mg three times daily provides adequate coverage for mild-to-moderate infections 1
- This regimen is recommended for acute bacterial rhinosinusitis when 10-day therapy is indicated 1
- For recurrent streptococcal pharyngitis in adults with multiple episodes, 500 mg twice daily for 10 days is recommended 1
Special Clinical Scenarios
- For animal or human bites: 500 mg/125 mg twice daily 1
- For early localized or disseminated Lyme disease with concurrent bacterial cellulitis: 500 mg three times daily for 14 days 1
- For chronic Group A streptococcal carriers with recurrent symptomatic episodes: 500 mg twice daily for 10 days 1
Intravenous Dosing
Standard IV Regimen
- For most serious infections including complicated intra-abdominal infections, severe respiratory infections, and severe skin/soft tissue infections: 1.2 g IV every 8 hours 1, 2
- Duration for intra-abdominal infections: 4-7 days with adequate source control 1
- Duration for skin and soft tissue infections: 7-10 days 2
- Duration for respiratory tract infections: 7-10 days depending on clinical response 2
Treatment Duration by Indication
- Uncomplicated acute bacterial rhinosinusitis: 5-7 days 1
- Streptococcal infections: minimum 10 days to prevent acute rheumatic fever 1
- Pneumonia: 5-7 days if afebrile for 48 hours and clinically stable 1
- Lyme disease with cellulitis: 14 days 1
Critical Dosing Considerations
Formulation Warnings
- Do NOT substitute two 250 mg tablets for one 500 mg tablet, as this results in excessive clavulanate dosing and increased gastrointestinal side effects 1
- IV dosing (1.2 g every 8 hours) should not be confused with oral dosing (875/125 mg twice daily), as these are different formulations with different pharmacokinetics 2
Renal Impairment
- Dosage adjustment is required in patients with severe renal impairment (GFR less than 30 mL/min), as amoxicillin is primarily eliminated by the kidney 3
- Amoxicillin may be removed from circulation by hemodialysis 3
Completion of Therapy
- Completing the full course of therapy is crucial to prevent treatment failure, resistance development, and complications such as acute rheumatic fever 1
- This applies regardless of clinical improvement 1
Pharmacokinetic Profile
- Peak blood levels occur 1-2 hours after oral administration 3
- The 875 mg tablet produces an AUC of 35.4 ± 8.1 mcg•hr/mL and a Cmax of 13.8 ± 4.1 mcg/mL 3
- Half-life of amoxicillin is 61.3 minutes 3
- Approximately 60% of an orally administered dose is excreted unchanged in urine within 6-8 hours 3
- Amoxicillin is approximately 20% protein-bound in blood serum 3
Common Pitfalls to Avoid
- Avoid using Augmentin as first-line therapy for uncomplicated Group A streptococcal pharyngitis—penicillin V or amoxicillin alone are preferred due to narrow spectrum, minimal adverse effects, and lower cost 1
- Reserve Augmentin for streptococcal carriers with recurrent symptomatic episodes, not routine acute pharyngitis 1
- For penicillin-allergic patients with acute strep pharyngitis, use cephalexin, clindamycin, azithromycin, or clarithromycin instead of Augmentin 1
- Consider avoiding aminoglycosides in combination with Augmentin when other nephrotoxic drugs are used or in renal dysfunction 4